文献
J-GLOBAL ID:201902265430849635
整理番号:19A1210592
EML4-ALK融合蛋白質を持つ非小細胞肺癌に対する長期アレクチニブ療法後の髄膜腫再発【JST・京大機械翻訳】
Leptomeningeal recurrence after long-term alectinib therapy for non-small cell lung cancer harboring an EML4-ALK fusion protein
著者 (11件):
Kawamura Takahisa
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Murakami Haruyasu
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Kobayashi Haruki
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Nakashima Kazuhisa
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Omori Shota
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Wakuda Kazushige
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Ono Akira
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Kenmotsu Hirotsugu
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Naito Tateaki
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Endo Masahiro
(Division of Diagnostic Radiology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
,
Takahashi Toshiaki
(Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan)
資料名:
Investigational New Drugs
(Investigational New Drugs)
巻:
37
号:
1
ページ:
184-187
発行年:
2019年
JST資料番号:
W4500A
ISSN:
1573-0646
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)